Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05343702
Other study ID # nisik
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 15, 2021
Est. completion date January 15, 2022

Study information

Verified date September 2023
Source Ankara City Hospital Bilkent
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Airway management and advanced airway management are the issues that are applied every day in emergency services and that the emergency physician should know best. Rapid sequential intubation is one of the most frequently used techniques in advanced airway management. However, anesthetic agents and paralytic agents have some concerns with some side effects. In our study, This study aimed to compare the effect of standard rapid sequential intubation protocol and application of rocuronium priming technique on the procedure time and hemodynamic profile.


Description:

This study is a prospective, observational and randomized study conducted between 15.07.2021 and 01.12.2021 in Ankara City Hospital Emergency Medicine Clinic, which is a third-level emergency department with approximately 450,000 patient admissions per year. Patients who applied to the emergency department and needed rapid sequential intubation were included in our study. Randomization was done according to the order of arrival of the cases. The demographic characteristics of the patients included in the study and the presence of diabetes mellitus were recorded. Routine rapid sequential intubation was performed in the standard group. In the priming group, 10% of the rocuronium dose was administered approximately 3 minutes before the induction agent. Intubation time, amount of drug used, vital signs before and after intubation, and end tidal carbon dioxide level to confirm intubation were recorded.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date January 15, 2022
Est. primary completion date December 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Be over the age of 18 - Need for advanced airway - To give consent or consent to participate in the study consent of relatives of those who are unable to give Exclusion Criteria: - Have an indication of a crush (rescue) airway - Have one of the difficult airway predictor Look, Evaluate, Obstruction, Neck mobility criteria - maxillofacial anomaly or trauma - detected during laryngoscopy with a cormack-lehane score of 3 and 4 patients - Those who have inconveniences in applying ketamine to the clinic of the patient - with a rocuronium or ketamine allergy

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
priming with rocuronium
Following induction (paralysis after onset of the induction effect) in routine rapid sequence intubation protocols While paralysis is applied, it is aimed to shorten the half-life of rocuronium by administering a subparalytic dose of rocuronium approximately 3-5 minutes before induction in the priming technique

Locations

Country Name City State
Turkey Ankara Bilkent Sehir Hastanesi Ankara

Sponsors (1)

Lead Sponsor Collaborator
Ankara City Hospital Bilkent

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary intubation time when successful endotracheal intubation is performed after induction ten minutes
Primary blood pressure systolic and diastolic mmhg ten minutes
Primary heart rate beats/minute ten minutes
Secondary indirect perfusion Indirect tissue perfusion interpretation with endtidal carbon dioxide levels ten minutes
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05515835 - Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.
Completed NCT01672606 - Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea N/A
Completed NCT05066035 - Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine Phase 4
Not yet recruiting NCT05067829 - Rapid Sequence Intubation With Rocuronium in Elderly Patients N/A
Recruiting NCT05028088 - Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex Phase 4
Completed NCT05476952 - Lean Body Weight-adjusted Rocuronium Dose and Intubation Conditions
Recruiting NCT04124757 - Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety N/A
Recruiting NCT02989272 - Effect of Pre-treatment With Magnesium Sulfate on the Duration of Deep Neuromuscular Blockade With Rocuronium Phase 4
Completed NCT04236050 - Continuous Infusion and Bolus Doses of Rocuronium During Lumbal Discectomy, Muscle Strength and Patient Recovery N/A
Recruiting NCT05217238 - Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium N/A
Recruiting NCT04821817 - Peribulbar Rocuronium in Adult Strabismus Surgery N/A
Enrolling by invitation NCT04760912 - General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery N/A